Follow
Pieter Annaert
Pieter Annaert
Full professor KU Leuven
Verified email at kuleuven.be - Homepage
Title
Cited by
Cited by
Year
Membrane transporters in drug development
Nature reviews Drug discovery 9 (3), 215-236, 2010
34722010
Systemic availability and metabolism of colonic‐derived short‐chain fatty acids in healthy subjects: a stable isotope study
E Boets, SV Gomand, L Deroover, T Preston, K Vermeulen, V De Preter, ...
The Journal of physiology 595 (2), 541-555, 2017
3502017
Ordered mesoporous silica material SBA-15: a broad-spectrum formulation platform for poorly soluble drugs
M Van Speybroeck, V Barillaro, T Do Thi, R Mellaerts, J Martens, ...
Journal of pharmaceutical sciences 98 (8), 2648-2658, 2009
3012009
Strategies for absorption screening in drug discovery and development
H Bohets, P Annaert, G Mannens, K Anciaux, P Verboven, ...
Current topics in medicinal chemistry 1 (5), 367-383, 2001
2942001
Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica
R Mellaerts, R Mols, JAG Jammaer, CA Aerts, P Annaert, ...
European Journal of Pharmaceutics and Biopharmaceutics 69 (1), 223-230, 2008
2862008
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2− infected hamsters, whereas hydroxychloroquine lacks activity
SJF Kaptein, S Jacobs, L Langendries, L Seldeslachts, S Ter Horst, ...
Proceedings of the National Academy of Sciences 117 (43), 26955-26965, 2020
2742020
Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica
M Van Speybroeck, R Mellaerts, R Mols, T Do Thi, JA Martens, ...
European Journal of Pharmaceutical Sciences 41 (5), 623-630, 2010
2282010
A review of drug solubility in human intestinal fluids: implications for the prediction of oral absorption
P Augustijns, B Wuyts, B Hens, P Annaert, J Butler, J Brouwers
European Journal of Pharmaceutical Sciences 57, 322-332, 2014
2012014
The FXR agonist obeticholic acid prevents gut barrier dysfunction and bacterial translocation in cholestatic rats
L Verbeke, R Farre, B Verbinnen, K Covens, T Vanuytsel, J Verhaegen, ...
The American journal of pathology 185 (2), 409-419, 2015
1982015
Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1
P Annaert, ZW Ye, B Stieger, P Augustijns
Xenobiotica 40 (3), 163-176, 2010
1922010
Antiretroviral efficacy and pharmacokinetics of oral bis (isopropyloxycarbonyloxymethyl) 9-(2-phosphonylmethoxypropyl) adenine in mice
L Naesens, N Bischofberger, P Augustijns, P Annaert, G Van den Mooter, ...
Antimicrobial agents and chemotherapy 42 (7), 1568-1573, 1998
1741998
Excipient-mediated supersaturation stabilization in human intestinal fluids
J Bevernage, T Forier, J Brouwers, J Tack, P Annaert, P Augustijns
Molecular pharmaceutics 8 (2), 564-570, 2011
1642011
Clinical determinants of calcineurin inhibitor disposition: a mechanistic review
T Vanhove, P Annaert, DRJ Kuypers
Drug metabolism reviews 48 (1), 88-112, 2016
1582016
Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation
I Spriet, P Annaert, P Meersseman, G Hermans, W Meersseman, ...
Journal of antimicrobial chemotherapy 63 (4), 767-770, 2009
1462009
Effect of pH and comedication on gastrointestinal absorption of posaconazole: monitoring of intraluminal and plasma drug concentrations
J Walravens, J Brouwers, I Spriet, J Tack, P Annaert, P Augustijns
Clinical pharmacokinetics 50, 725-734, 2011
1432011
In vitro hepatic metabolism explains higher clearance of voriconazole in children versus adults: role of CYP2C19 and flavin-containing monooxygenase 3
SB Yanni, PP Annaert, P Augustijns, JG Ibrahim, DK Benjamin, ...
Drug Metabolism and Disposition 38 (1), 25-31, 2010
1432010
High intrapatient variability of tacrolimus concentrations predicts accelerated progression of chronic histologic lesions in renal recipients
T Vanhove, T Vermeulen, P Annaert, E Lerut, DRJ Kuypers
American Journal of Transplantation 16 (10), 2954-2963, 2016
1362016
Structure-based identification of OATP1B1/3 inhibitors
T De Bruyn, GJP Van Westen, AP IJzerman, B Stieger, P de Witte, ...
Molecular pharmacology 83 (6), 1257-1267, 2013
1362013
Intestinal drug solubility estimation based on simulated intestinal fluids: comparison with solubility in human intestinal fluids
S Clarysse, J Brouwers, J Tack, P Annaert, P Augustijns
European Journal of Pharmaceutical Sciences 43 (4), 260-269, 2011
1362011
Combined use of ordered mesoporous silica and precipitation inhibitors for improved oral absorption of the poorly soluble weak base itraconazole
M Van Speybroeck, R Mols, R Mellaerts, T Do Thi, JA Martens, ...
European Journal of Pharmaceutics and Biopharmaceutics 75 (3), 354-365, 2010
1352010
The system can't perform the operation now. Try again later.
Articles 1–20